DELTEX2 C-terminal domain recognizes and recruits ADP-ribosylated proteins for ubiquitination.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
08 2020
Historique:
received: 03 04 2020
accepted: 09 07 2020
entrez: 16 9 2020
pubmed: 17 9 2020
medline: 13 4 2022
Statut: epublish

Résumé

Cross-talk between ubiquitination and ADP-ribosylation regulates spatiotemporal recruitment of key players in many signaling pathways. The DELTEX family ubiquitin ligases (DTX1 to DTX4 and DTX3L) are characterized by a RING domain followed by a C-terminal domain (DTC) of hitherto unknown function. Here, we use two label-free mass spectrometry techniques to investigate the interactome and ubiquitinated substrates of human DTX2 and identify a large proportion of proteins associated with the DNA damage repair pathway. We show that DTX2-catalyzed ubiquitination of these interacting proteins requires PARP1/2-mediated ADP-ribosylation and depends on the DTC domain. Using a combination of structural, biochemical, and cell-based techniques, we show that the DTX2 DTC domain harbors an ADP-ribose-binding pocket and recruits poly-ADP-ribose (PAR)-modified proteins for ubiquitination. This PAR-binding property of DTC domain is conserved across the DELTEX family E3s. These findings uncover a new ADP-ribose-binding domain that facilitates PAR-dependent ubiquitination.

Identifiants

pubmed: 32937373
pii: 6/34/eabc0629
doi: 10.1126/sciadv.abc0629
pmc: PMC7442474
pii:
doi:

Substances chimiques

Ubiquitin 0
Poly Adenosine Diphosphate Ribose 26656-46-2
Adenosine Diphosphate 61D2G4IYVH
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Cancer Research UK
ID : 29256
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A23278
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Methods Enzymol. 2005;399:3-20
pubmed: 16338345
Mol Ther. 2015 Feb;23(2):255-69
pubmed: 25327178
Protein Eng. 1993 Jan;6(1):37-40
pubmed: 8433969
J Clin Invest. 2017 Apr 3;127(4):1225-1240
pubmed: 28263185
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Acta Crystallogr D Struct Biol. 2018 Feb 1;74(Pt 2):85-97
pubmed: 29533234
Nat Struct Mol Biol. 2012 Jan 22;19(2):184-92
pubmed: 22266821
FEBS Lett. 2012 Nov 2;586(21):3858-64
pubmed: 23010590
Nat Cell Biol. 2011 May;13(5):623-9
pubmed: 21478859
Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82
pubmed: 16369096
J Proteome Res. 2019 May 3;18(5):2052-2064
pubmed: 30931570
Nat Struct Mol Biol. 2012 Sep;19(9):876-83
pubmed: 22902369
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Structure. 2005 Nov;13(11):1599-611
pubmed: 16271883
Annu Rev Biochem. 2012;81:203-29
pubmed: 22524316
Nat Struct Mol Biol. 2013 Aug;20(8):982-986
pubmed: 23851457
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Development. 1995 Aug;121(8):2633-44
pubmed: 7671825
Mol Cell Biol. 2013 Feb;33(4):845-57
pubmed: 23230272
Mol Cell. 2013 Oct 24;52(2):272-85
pubmed: 24055347
Mol Cell. 2012 Jun 29;46(6):722-34
pubmed: 22749398
Proteins. 2012 May;80(5):1495-9
pubmed: 22411408
Nature. 2015 Jan 8;517(7533):223-6
pubmed: 25327252
Methods Mol Biol. 2011;780:209-26
pubmed: 21870263
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Sci Signal. 2017 Jun 13;10(483):
pubmed: 28611181
Annu Rev Biophys Biomol Struct. 2007;36:131-50
pubmed: 17477837
Acta Crystallogr D Biol Crystallogr. 1996 Jul 1;52(Pt 4):842-57
pubmed: 15299650
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nucleic Acids Res. 2017 Aug 21;45(14):8129-8141
pubmed: 28854736
Int J Dev Neurosci. 2001 Feb;19(1):21-35
pubmed: 11226752
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10037-41
pubmed: 11517324
Annu Rev Biochem. 2009;78:399-434
pubmed: 19489725
Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621
pubmed: 28676700
Acta Crystallogr D Struct Biol. 2017 Feb 1;73(Pt 2):148-157
pubmed: 28177311
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14
pubmed: 23793146
Science. 1998 Jun 5;280(5369):1614-7
pubmed: 9616126
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Mol Cell. 2017 Oct 19;68(2):456-470.e10
pubmed: 29053960
J Mol Biol. 2011 Nov 25;414(2):243-59
pubmed: 22001695
Genes Dev. 2012 Feb 1;26(3):235-40
pubmed: 22267412
Nucleic Acids Res. 2017 Jun 2;45(10):6254
pubmed: 28100694
Trends Biochem Sci. 2001 May;26(5):273-5
pubmed: 11343911
Genomics Proteomics Bioinformatics. 2016 Jun;14(3):131-139
pubmed: 27240471
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14103-8
pubmed: 21825151
J Biol Chem. 2003 Jun 13;278(24):21930-7
pubmed: 12670957
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
J Cell Biol. 2010 May 17;189(4):739-54
pubmed: 20479470
Genes Dev. 2017 Jan 15;31(2):101-126
pubmed: 28202539
Annu Rev Biochem. 1998;67:425-79
pubmed: 9759494
Mol Cell. 2009 Oct 9;36(1):110-20
pubmed: 19818714

Auteurs

Syed Feroj Ahmed (SF)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Lori Buetow (L)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Mads Gabrielsen (M)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Sergio Lilla (S)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Chatrin Chatrin (C)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.

Gary J Sibbet (GJ)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Sara Zanivan (S)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.
Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.

Danny T Huang (DT)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK. d.huang@beatson.gla.ac.uk.
Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH